Literature DB >> 2522249

Coagulation cascade, fibrinolytic system, antithrombin III, protein C and protein S in patients maintained on continuous ambulatory peritoneal dialysis.

N D Vaziri1, G M Shah, R L Winer, E Gonzales, B Patel, S Alikhani, Q X Nguyen, J Yamamoto.   

Abstract

We studied the coagulation cascade, fibrinolytic system and naturally occurring anticoagulants in a group of 14 patients with end-stage renal disease maintained on continuous ambulatory peritoneal dialysis (CAPD). The results were compared with those obtained in a group of ten normal volunteers. Plasma procoagulant activities of factors XII, XI, IX, VIII, VII, X and II were significantly greater in the CAPD group as compared to the normal control group. Likewise plasma concentrations of total and free protein S were increased in the CAPD group. Although the mean value for plasma factor V activity in the CAPD group was higher than that found in the control group the difference did not attain statistical significance. In addition plasma fibrinogen concentration and factor VIII-related antigen level were significantly increased in CAPD patients. No significant difference was found between the CAPD patients and the control group with respect to plasma levels of protein C, antithrombin III, plasminogen or alpha 2-antiplasmin. In summary, the results demonstrate a tendency for increased levels of various coagulation factors and protein S in CAPD patients with no significant alterations in the levels of various fibrinolytic and endogenous anticoagulant agents, i.e. antithrombin III and protein C. The clinical significance and the mechanism responsible for the observed changes require further investigation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522249     DOI: 10.1016/0049-3848(89)90377-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Protein Z and natural anticoagulants in children on peritoneal dialysis and hemodialysis.

Authors:  Kenan Bek; Ozan Ozkaya; Tunç Fişgin; Yüksel Aliyazicioğlu; M Sükrü Paksu; Tolga Ozgen; Davut Albayrak; Kemal Baysal
Journal:  Pediatr Nephrol       Date:  2006-11-24       Impact factor: 3.714

Review 2.  The Role of Peritoneal Dialysis in Different Phases of Kidney Transplantation.

Authors:  Ali I Gardezi; Fahad Aziz; Sandesh Parajuli
Journal:  Kidney360       Date:  2022-02-28

3.  Coagulation inhibitors and fibrinolytic parameters in patients on peritoneal dialysis and haemodialysis.

Authors:  J Alwakeel; A M Gader; S Hurieb; A K al-Momen; A Mitwalli; H Abu Aisha
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

Review 4.  Antiplatelet Therapy in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions.

Authors:  Francesco Summaria; Maria B Giannico; Giovanni P Talarico; Roberto Patrizi
Journal:  Nephrourol Mon       Date:  2015-07-22

5.  Preemptively and non-preemptively transplanted patients show a comparable hypercoagulable state prior to kidney transplantation compared to living kidney donors.

Authors:  Gertrude J Nieuwenhuijs-Moeke; Tamar A J van den Berg; Stephan J L Bakker; Marius C van den Heuvel; Michel M R F Struys; Ton Lisman; Robert A Pol
Journal:  PLoS One       Date:  2018-07-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.